Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer.

about

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer.

Item

http://www.wikidata.org/entity/Q40975780

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Long-term survival benefit of ...... resectable pancreatic cancer.

@en

type

Item

label

Long-term survival benefit of ...... resectable pancreatic cancer.

@en

prefLabel

Long-term survival benefit of ...... resectable pancreatic cancer.

@en

P1476

Long-term survival benefit of ...... resectable pancreatic cancer.

@en

P2093

Adrian Murphy

http://www.w3.org/2001/XMLSchema#string

Amol Narang

http://www.w3.org/2001/XMLSchema#string

Amy Hacker-Prietz

http://www.w3.org/2001/XMLSchema#string

Ana De Jesus-Acosta

http://www.w3.org/2001/XMLSchema#string

Avani S Dholakia

http://www.w3.org/2001/XMLSchema#string

Bikram Shrestha

http://www.w3.org/2001/XMLSchema#string

Chiung-Yu Huang

http://www.w3.org/2001/XMLSchema#string

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

Daniel A Laheru

http://www.w3.org/2001/XMLSchema#string

Dung T Le

http://www.w3.org/2001/XMLSchema#string

P2860

Recent progress in pancreatic cancer

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer

Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement

Venous resection in pancreatic cancer surgery.

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.

P304

1552-1562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1104

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28639410

http://www.w3.org/2001/XMLSchema#string

P932

5504321

http://www.w3.org/2001/XMLSchema#string